• Advocacy Masterclass
  • Patient Storybook
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
    • We The Patients Fly-in 2023
    • Patient StoryBook
    • What You Can Do
    • Patient Action Center
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions
    • Legislative Positions
    • Positions
    • Policy Supported
  • Take Action
    • We The Patients Fly-in 2023
    • Patient StoryBook
    • What You Can Do
    • Patient Action Center
    • Advocacy Masterclass
  • Donate

davis

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Sends Comments to FDA on OTC Naloxone

Feb 14, 2023 | FDA, Featured

Patients Rising Now submitted comments to the Food and Drug Administration (FDA) on making naloxone available as an over-the-counter treatment. Naloxone is a treatment which prevents death in the event of an opioid overdose and is currently only available through...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Signs onto Letter to CMS on Step Therapy

Feb 13, 2023 | Featured, Letters Supported

Patients Rising Now joined 58 other organizations in a letter sent to the Centers for Medicare and Medicaid (CMS) on reinstating a Federal Rule prohibiting step therapy in Medicare Advantage plans. In 2012, CMS instituted a prohibition on step therapy in Medicare...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Sends Letter to EEOC on the QALY

Feb 10, 2023 | Featured, QALY, Uncategorized

Patients Rising Now sent a letter to the Equal Employment Opportunity Commission (EEOC) regarding the release of its draft Strategic Enforcement Plan (SEP). The draft SEP outlined several new policy changes to enhance protections for employees from vulnerable...
Read more
Patients Rising Now Sends Comments to FDA on OTC Naloxone

Patients Rising Now Signs onto Letter to CMS on Low Income Subsidies

Feb 7, 2023 | Comment Letters

Patients Rising Now joined 70 other patients groups in a letter to the Centers for Medicare and Medicaid Services (CMS) on the expansion of the Low Income Subsidy (LIS). As part of the Inflation Reduction Act (IRA), the LIS was expanded to include beneficiaries who...
Read more
Patients Rising Now Weighs in on House E&C QALY Hearing

Patients Rising Now Weighs in on House E&C QALY Hearing

Feb 2, 2023 | Featured Action, QALY

The House Energy and Commerce (E&C) Health Subcommittee held a hearing on banning the use of the Quality-Adjusted Life Year (QALY) in Federal health programs. The Protecting Health Care for All Patients Act (H.R.485) was recently reintroduced by Chairwoman Rodgers...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Out-of-the-Box Thinking Needed to Boost Healthcare Professional Workforce, Improve Access 
  • Patient Group Exposes Vision Benefit Manager Abuses in New Campaign
  • Wilcox: A Bipartisan Victory for Patients to Ban Discriminatory Metrics Congressional Subcommittee Agrees: Patient Lives are WORTH IT 
  • Patients Rising Now Submits Comments on Patient Rights to United States Patent and Trademark Office
  • New Harris Poll:  FDA Should Regulate All Medical Device Service and Repair

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now